Reshape Clinic
Lahore, Pakistan
NCT Number: NCT07048626
Low-level laser stimulates cells in the hair follicles, which promotes hair growth. The patient's own blood platelets are used in platelet-rich plasma treatment to encourage hair growth. Combining low-level laser treatment with platelet-rich plasma will promote hair growth in patients.
This study is active but is not currently recruiting participants.
Notify Me20 year–35 year
All sexes
Interventional
Not applicable
Lahore, Pakistan
To determine the impact of low-level laser therapy on hair regrowth following prp treatment.
This will be case control study conducted on 22 participants with androgenetic alopecia (AGA).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PRP treatment involves drawing a blood sample, processing it to concentrate platelets, and then injecting that concentrated plasma back into the body, typically at the site of an injury or area needing regeneration. The procedure aims to utilize the growth factors within the platelets to accelerate healing and tissue repair.
will receive low-level laser therapy post prp treatment upto 12 weeks .Low-level laser therapy (LLLT) is a non-invasive treatment for hair loss that uses low-intensity laser light to stimulate hair follicles and improve blood circulation. It's often used on its own or combined with other therapies like PRP.
Time frame: 12 Months
The Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity
Superior University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07011485
Alopecia, Alopecia, Androgenetic
Koppal, Karnataka, India
View Trial DetailsNCT07107841
Alopecia, Androgenic Alopecia
West Hollywood, California, United States
View Trial DetailsNCT01904721
Alopecia, Alopecia, Androgenetic
Fridley, Minnesota, United States
View Trial DetailsNCT01325337
Alopecia, Alopecia, Androgenetic
Portland, Oregon, United States
View Trial Details